Impact Factor
2.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.32
163 total citations
h5-index
16
h5 depth signal
Cited share
51.9%
40 of 77
Total citations
163
Citation footprint
Metric signal
2.14
External metric anchor
Self-citation
7.4%
12 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
252
United States
21
Iran
11
Ireland
10
India
7
Citing Fields of Research
Endocrine Therapy
204
Reproductive Health
110
Human Reproduction
92
Obstetrics/Gynecology
39
Urology
19
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,260
Articles tracked across the journal lifetime
Indexed publication set
77
40 cited publications
Last 12 months
38
3.8 publications/month
Open access share
18.4%
7 OA publications in the last year
Leading citing country
United Kingdom
252 citing publications
Leading citing field
Endocrine Therapy
204 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v20n1, March 2014-
v20n1, March 2014-
Research Focus & Classification
Indexed Subjects
Endocrine Therapy
Issuing & Sponsoring Bodies
issuing body
British Menopause Society
Broad Categories
Gynecology
Endocrine Therapy
MeSH Descriptors
Menopause
Women's Health
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/20533691.2026.2741118
Open DOI
Menopausal symptom severities and patterns are affected by medical profiles
02
DOI 10.1080/20533691.2026.2743698
Open DOI
Should menopause care measure function? Functional Menopause as a testable research framework
03
DOI 10.1080/20533691.2026.2728619
Open DOI
Digital health innovations: imagining opportunities to support people with a learning disability experiencing menopause
04
DOI 10.1080/20533691.2026.2719474
Open DOI
Accessing support for menopause-associated cognitive difficulties in UK primary care: a qualitative content analysis
1. It has been estimated that approximately 13 million women, or one-third of the female population in the UK, are peri- or post-menopausal [1]. Between 50-75% of women experience symptoms during m...
05
DOI 10.1080/20533691.2026.2719463
Open DOI
A user-centric patient educational intervention in clinical practice: helping women to learn and share experiences about menopause
06
DOI 10.1080/20533691.2026.2706024
Open DOI
Evaluation of sexual function according to age in women referred to urogynaecology clinics
Women are living longer with better health in later life than in preceding generations and are remaining sexually active into older age. Evidence from population studies suggests that ‘older men an...
07
DOI 10.1080/20533691.2026.2704833
Open DOI
Association between body composition and perimenopausal symptom severity in Irish women
Menopause which is defined retrospectively after 12 consecutive months of amenorrhoea, marks the end of female fertility and occurs due to a progressive decline in ovarian function as part of the n...
08
DOI 10.1080/20533691.2026.2706025
Open DOI
Tendinopathies in physically active post-menopausal women: a concise review
09
DOI 10.1080/20533691.2026.2701000
Open DOI
A bus crossing on Mull: consent, communication, and the missing hormonal continuum
Seven weeks after my surgeon removed my uterus and ovaries to treat my endometrial cancer with laparoscopic surgery, I was on the upper deck of a tour bus crossing the Isle of Mull. Gazing out the ...
10
DOI 10.1080/20533691.2026.2705046
Open DOI
Menopausal ‘brain fog’ or dementia?—a practical guide for clinicians
Menopausal ‘brain fog’ is a cluster of cognitive-related symptoms that can be distressing to individuals.Brain fog can occur across the lifespan in both men and women. It is not always hormone rela...
Bibliographical & Catalog Notes
Also issued online.